Emergent BioSolutions Inc (EBS)
4.345
-0.02
(-0.57%)
USD |
NYSE |
May 10, 16:00
4.345
0.00 (0.00%)
After-Hours: 18:13
Emergent BioSolutions Debt to Equity Ratio: 1.364 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 1.364 |
December 31, 2023 | 1.325 |
September 30, 2023 | 1.236 |
June 30, 2023 | 0.9445 |
March 31, 2023 | 1.163 |
December 31, 2022 | 1.013 |
September 30, 2022 | 0.7268 |
June 30, 2022 | 0.5453 |
March 31, 2022 | 0.5289 |
December 31, 2021 | 0.5219 |
September 30, 2021 | 0.5575 |
June 30, 2021 | 0.5532 |
March 31, 2021 | 0.5642 |
December 31, 2020 | 0.6046 |
September 30, 2020 | 0.7027 |
June 30, 2020 | 0.6567 |
March 31, 2020 | 0.7343 |
December 31, 2019 | 0.7453 |
September 30, 2019 | 0.7956 |
June 30, 2019 | 0.8499 |
March 31, 2019 | 0.7519 |
December 31, 2018 | 0.786 |
September 30, 2018 | 0.014 |
June 30, 2018 | 0.0144 |
March 31, 2018 | 0.0153 |
Date | Value |
---|---|
December 31, 2017 | 0.0148 |
September 30, 2017 | 0.3752 |
June 30, 2017 | 0.4007 |
March 31, 2017 | 0.4069 |
December 31, 2016 | 0.4497 |
September 30, 2016 | 0.489 |
June 30, 2016 | 0.3678 |
March 31, 2016 | 0.3706 |
December 31, 2015 | 0.3741 |
September 30, 2015 | 0.418 |
June 30, 2015 | 0.45 |
March 31, 2015 | 0.4666 |
December 31, 2014 | 0.4537 |
September 30, 2014 | 0.4891 |
June 30, 2014 | 0.5146 |
March 31, 2014 | 0.5257 |
December 31, 2013 | 0.1266 |
September 30, 2013 | 0.1272 |
June 30, 2013 | 0.1347 |
March 31, 2013 | 0.1415 |
December 31, 2012 | 0.1422 |
September 30, 2012 | 0.1476 |
June 30, 2012 | 0.1482 |
March 31, 2012 | 0.1486 |
December 31, 2011 | 0.1435 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5219
Minimum
Dec 2021
1.364
Maximum
Mar 2024
0.8066
Average
0.7306
Median
Debt to Equity Ratio Benchmarks
Avid Bioservices Inc | 0.7849 |
Viking Therapeutics Inc | -- |
FibroGen Inc | -0.3166 |
Avinger Inc | -2.305 |
RAPT Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.804B |
Total Liabilities (Quarterly) | 1.140B |
Shareholders Equity (Quarterly) | 663.90M |
Current Ratio | 1.083 |
Net Debt Paydown Yield | 75.42% |